|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 51.52 USD | -1.79% |
|
+6.14% | +30.23% |
| 09-04 | Atricure Insider Sold Shares Worth $407,558, According to a Recent SEC Filing | MT |
| 09-02 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
Business description: AtriCure, Inc.
Number of employees: 1,350
Sales by Activity: AtriCure, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
The Development, Manufacture, And Sale Of Devices Used In Surgical Procedures | 274M | 330M | 399M | 465M | 535M |
Geographical breakdown of sales: AtriCure, Inc.
| Fiscal Period: December | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 229M | 277M | 334M | 383M | 435M |
Europe | 27.93M | 30.43M | 38.47M | 49.87M | 61.49M |
Asia Pacific | 16.08M | 20.73M | 24.53M | 27.38M | 30.72M |
Other International | 1.19M | 2.02M | 2.71M | 5.24M | 6.94M |
Executive Committee: AtriCure, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Carrel
CEO | Chief Executive Officer | 55 | 2012-11-01 |
Angela Wirick
DFI | Director of Finance/CFO | 48 | 2014-06-30 |
| Chief Tech/Sci/R&D Officer | 59 | 2017-07-17 | |
| Chief Tech/Sci/R&D Officer | 54 | 2017-02-28 | |
Douglas Seith
COO | Chief Operating Officer | 60 | 2015-01-13 |
Composition of the Board of Directors: AtriCure, Inc.
| Director | Title | Age | Since |
|---|---|---|---|
Michael Carrel
BRD | Director/Board Member | 55 | 2012-11-01 |
Robert White
BRD | Director/Board Member | 64 | 2013-03-10 |
Sven Wehrwein
BRD | Director/Board Member | 75 | 2016-11-09 |
Regina Groves
BRD | Director/Board Member | 67 | 2017-03-20 |
B. Johnson
CHM | Chairman | 74 | 2021-05-19 |
Karen Prange
BRD | Director/Board Member | 62 | 2019-12-03 |
Maggie Yuen
BRD | Director/Board Member | 54 | 2021-06-14 |
Deborah Telman
BRD | Director/Board Member | 61 | 2021-06-14 |
Shlomi Nachman
BRD | Director/Board Member | 64 | 2024-01-02 |
Company details: AtriCure, Inc.
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.79% | +6.14% | +45.62% | +14.87% | 2.62B | |
| -0.42% | -3.68% | -18.51% | +6.67% | 187B | |
| +1.15% | +3.22% | +1.37% | +16.68% | 120B | |
| -1.86% | +2.77% | +13.15% | +89.47% | 63.15B | |
| -1.31% | -1.09% | +17.67% | +43.65% | 51.75B | |
| -1.54% | -2.52% | -3.98% | -30.72% | 50.32B | |
| -2.02% | -3.22% | +9.18% | -17.76% | 33.17B | |
| 0.00% | +3.71% | - | - | 32.1B | |
| -0.81% | +0.74% | +35.59% | -16.03% | 23.93B | |
| -1.44% | -4.21% | -8.07% | +11.30% | 22.99B | |
| Average | -1.00% | +0.55% | +10.22% | +13.13% | 58.79B | |
| Weighted average by Cap. | -0.56% | +0.05% | -1.21% | +16.10% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATRC Stock
- Company AtriCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
